In addition, this study shows a reduction of both extracellular signal-regulated kinase (ERK) activity and mTOR phosphorylation levels in the Fmr1 KO but not in wild-type (WT) animals, suggesting that they could represent potential biomarkers in FXS [53]. The gene discussed is FMR1; the disease is fragile X syndrome.